FDA scolds SPL in manufacturing warning
The FDA has issued a warning letter to Scientific Protein Laboratories, one of the companies at the center of the heparin scandal in 2008, raising several questions about its handling of the drug. Report
THE LIBRARY: WEBINAR
Getting the most PoC data in Phase I cancer studies
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
Latest Commentary
EVENTS
- MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
- Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
- What's your BIO?June 18-21, 2012 — Boston, MA
Press Releases
- Recipharm secures financing for future growth
- PPD Names David Simmons Chairman and CEO
- Pfizer Names Olivier Brandicourt as President and General Manager, Emerging Markets and Established Products Business Units
- PPD Names David Simmons Chairman and CEO
- NICE recommends new treatment option for people with common heart condition
- More Press Releases
Featured Jobs
-
Sr. Manager, Patient Marketing
Vivus, Inc. - Mountain View, CA -
Scientist II Job
Yoh - Niskayuna, NY, USA -
District Sales Manager
Vivus, Inc. - -
Sr. Director/Executive Director of Operations, Inflammation and Immunology CRD Job
Celgene Corporation - Tokyo, Ja, US -
Pharmacist (Drug Safety and Product Information) Job
Yoh - Durham, NC, USA
Comments